| Similar Articles |
|---|
 |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists.   |
The Motley Fool
September 24, 2009
Brian Orelli |
Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share. |
American Family Physician
July 15, 2004 |
HIV Infection - How to Lower Your Risk A consumer-oriented brochure discussing the many ways to lower the risk of getting human immunodeficiency virus (HIV) infection and where to go for help. |
Fast Company
August 8, 2011
Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
Scientific American
October 2008
John Rennie |
Hope and the Fight against HIV The battle must continue, even if 25 years of research have disappointed. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Salon.com
October 20, 2000
David Tuller |
The buzz about blow jobs A study now underway hopes to isolate risk factors of transmitting HIV through oral sex... |
Chemistry World
July 17, 2012
Andrew Turley |
First HIV drug approved as prevention US regulators have for the first time approved a drug to be used to prevent HIV infection -- as opposed to treating it. |
The Motley Fool
April 6, 2010
Brian Orelli |
Kill It! Double-Teaming Malaria Malaria vaccine might not make Glaxo and Crucell rich, but the life-saving and PR benefits would be welcome. |
The Motley Fool
July 16, 2011
Melly Alazraki |
HIV Studies May Not Mean Much to Gilead Studies find Gilead drugs can help prevent HIV infections, but that may not help sales. |
American Family Physician
July 15, 2004
Joel E. Gallant |
HIV Counseling, Testing, and Referral By the year 2005, the CDC seeks to achieve the following: reduce annual new HIV infections from the current estimated 40,000 cases to 20,000 cases through the use of interventions such as counseling, HIV testing, and referral |
American Family Physician
May 15, 2002 |
HIV in Women What are HIV and AIDS?... How do women become infected with HIV?... Is HIV infection different in women and men?... What precautions can be taken to avoid getting HIV during sex?... What should I do if I think I may be infected?... |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
Salon.com
December 1, 2000
Fiona Morgan |
It's World AIDS Day ... again Americans with insurance now improve with new drugs, but the disease is on a rampage across the rest of the world... |
Salon.com
May 8, 2001
Daryl Lindsey |
The "Joe Camel" ads of AIDS? The FDA says ads for drugs to suppress HIV are making false promises, and could be contributing to an epidemic of unsafe sex... |
Chemistry World
February 9, 2007
Victoria Gill |
Africa's First Large-Scale HIV Vaccine Trial The first large-scale clinical trial of an HIV vaccine will involve around 3000 participants in five selected sites in South Africa. It will compare the effectiveness of the vaccine at reducing HIV infection compared to a placebo. |
The Motley Fool
April 3, 2008
Brian Lawler |
A Punch to Gilead's Competition A rival compound's bad data signals a better future for Gilead's lead drugs. |
The Motley Fool
April 16, 2009
Brian Orelli |
2 Virus Killers Are Better Than 1 Glaxo brings Pfizer under its HIV wing. |
Salon.com
September 14, 2000
David Tuller |
Seeing red Gay men have long been infuriated by a government ban on their donating blood. This week the FDA is reconsidering its position. |
AskMen.com
Dave Golokhov |
Truvada With more and more studies finding successful AIDS prevention, it looks like we're getting closer to finding a cure. |
The Motley Fool
December 21, 2004
Brian Gorman |
Bristol-Myers, Gilead Team Up The drugmakers' alliance will benefit both the companies and HIV patients. |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
Salon.com
June 22, 2001
Alicia Montgomery |
A deadly taboo Is homophobia in the black community fanning the flames of HIV infection among African-Americans, the hardest-hit population outside sub-Saharan Africa? |
Pharmaceutical Executive
November 1, 2014
Casey McDonald |
Advocacy Beat: Progress in Global Access to TB Drugs Treatment Action Group reaches a milestone in improving access to much-needed treatments for tuberculosis. |
The Motley Fool
May 8, 2009
Brian Orelli |
Glaxo Goes Head-to-Head on HPV Glaxo's data may not be enough to help Cervarix knock Merck's Gardasil from the top papillomavirus vaccine spot. |
Chemistry World
September 24, 2015 |
A new hope in HIV prevention New microbicide products could turn the tide against Aids for those who need it most: women in sub-Saharan Africa. Dinsa Sachan reports. |
Popular Mechanics
December 1, 2006
Ben Harder |
Fighting HIV by Building a New Killer In the fight to find a cure for AIDS, researchers have invented a viral double agent on a mission to seek out where HIV hides. |
Salon.com
March 28, 2001
Nina Siegal |
A plague undetected Did shady backroom hormone treatments and dirty needles cause a killer outbreak of HIV in the transgender community? |
The Motley Fool
June 26, 2008
Brian Lawler |
Gauging Glaxo's Vaccine Value Surprise! The FDA actually approves Glaxo's new combination children's vaccine without delay. |
American Family Physician
May 15, 2002
Alex H. Krist & Amy Crawford-Faucher |
Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues... |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV. |
The Motley Fool
February 4, 2010
Brian Orelli |
Glaxo Brings Home the Bacon Swine flu gives GlaxoSmithKline the boost, but how long will it last? |
The Motley Fool
September 7, 2005
Stephen D. Simpson |
Smashing Good Deal, Eh? Glaxo's purchase of Canadian ID Biomedical will seriously augment its vaccine capabilities. Investors, take note. |
American Family Physician
May 1, 2004
Daniel Knight |
Health Care Screening for Men Who Have Sex with Men Recommendations on health care screenings for men who have sex with men, who are at increased risk for STDs such as HIV infection, anal cancer, and psychologic and behavioral disorders. |
Salon.com
June 5, 2001
Michelangelo Signorile |
My story was ethical Writer Andrew Sullivan's pronouncements on AIDS and other gay issues made his personal life fair game... |
American Journal of Nursing
March 2010
David E. Vance |
Aging with HIV: Clinical Considerations for an Emerging Population Since the advent of highly active antiretroviral therapy, HIV infection has become a chronic, albeit life-threatening, condition that can be managed; therefore, more and more people are growing older with HIV. |
The Motley Fool
July 13, 2004
Charly Travers |
With Pfizer Drug, HIV Retreats Pfizer's newest HIV treatment shows promise in a demanding market. |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
The Motley Fool
January 21, 2010
Brian Orelli |
The Noble Gesture That Wasn't There may be a motive behind Glaxo helping to develop malaria treatments. |
The Motley Fool
July 28, 2005
Stephen D. Simpson |
Glaxo Keeps It Going Despite missing sales from the depression franchise, Glaxo managed to post respectable quarterly results. |
American Family Physician
January 1, 2001 |
HIV Infection and Pregnancy-Protecting Your Baby and Yourself Why should I be tested for HIV if I am pregnant?... How do babies get HIV?... What can I do to keep my baby from getting HIV?... What antiretroviral medicines should I be taking?... Should I have an elective cesarean section?... |
American Family Physician
May 15, 2002 |
HIV: Coping with the Diagnosis I'm scared. How can I cope with my fear?... What can I do to help myself?... Who should know I have HIV?... What legal issues should I consider?... |
The Motley Fool
November 9, 2006
Brian Lawler |
The Best Blue Chip for 2007: GlaxoSmithKline Here's a blue-chip pharma stock for your portfolio. |
Salon.com
July 13, 2000
Megan Williams |
African mothers: Save us, too AIDS activists say providing drugs to prevent HIV transmission to babies but not treating their mothers is unconscionable. |
Salon.com
July 21, 2000
Stephen Lemons |
Sex with latex Porn industry workers and prostitutes have to balance profit and safety, and their choices about using protection can inform us all. |
The Motley Fool
February 8, 2008
Brian Lawler |
Hold on to GlaxoSmithKline This might be a tough year for the big pharma company, but its pipeline makes it a keeper. |
The Motley Fool
December 17, 2008
Brian Orelli |
A Super-Cheap Call Option GlaxoSmithKline announces it's partnering up with tiny Dynavax Technologies to develop up to four drugs for autoimmune and inflammatory diseases. The pay-if-the-drug-works scheme should pay off. |
The Motley Fool
April 1, 2011
Brian Orelli |
Abbott: Battle Lost, War Won A jury ordered Abbott to pay GlaxoSmithKline $3.5 million. It could have been a lot worse. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
The Motley Fool
April 27, 2006
Stephen D. Simpson |
Glaxo's Story Still Worth Reading A good pipeline could keep GlaxoSmithKline's already-impressive shares rolling. |
